FDA Approved: TIVDAK — Original Application (SEAGEN INC.)

View source ↗

Summary

FDA approves Tivdak (tisotumab vedotin) under an original Biologics License Application from Seagen. It is approved for adult patients with recurrent or metasta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• TIVDAK (tisotumab vedotin)

Snippet

ORIG AP for TIVDAK (TISOTUMAB VEDOTIN)